Phase I safety clinical trial of peanut allergy vaccine, Polyvac® Peanut.

Trial Profile

Phase I safety clinical trial of peanut allergy vaccine, Polyvac® Peanut.

Planning
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2017

At a glance

  • Drugs Peanut allergy VLP Vaccine Allergy Therapeutics (Primary)
  • Indications Peanut hypersensitivity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Mar 2017 New trial record
    • 01 Feb 2017 According toa an Allergy Therapeutics media release, company plans to proceed to Phase I development of this vaccine following completion of this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top